CFM
VERA icon

Capricorn Fund Managers’s Vera Therapeutics VERA Stock Holding History

Capricorn Fund Managers’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-64,604
Closed -$2.6M – 213
2026
Q1 		$2.6M Buy
+64,604
New +$2.78M 0.41% 64
2025
Q4 		– Sell
-450,700
Closed -$13.1M – 106
2025
Q3 		$13.1M Buy
+450,700
New +$10.4M 4.4% 4

Other funds holding VERA

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

Capricorn Fund Managers's VERA Position: Q2 2026 in Review

Capricorn Fund Managers sold out of Vera Therapeutics (VERA) in Q2 2026, closing a stake of 64,604 shares — an estimated $2.6M sold.

Capricorn Fund Managers first reported a position in VERA in Q3 2025 and held it in 2 quarters. The position peaked at $13.1M in Q3 2025. 32 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Capricorn Fund Managers reported no remaining Vera Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Capricorn Fund Managers sold 64,604 Vera Therapeutics shares in Q2 2026, an estimated $2.6M.
  • Capricorn Fund Managers first reported a position in Vera Therapeutics in Q3 2025 and held it in 2 quarters.
  • Capricorn Fund Managers's Vera Therapeutics position peaked at $13.1M in Q3 2025.
  • 32 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Capricorn Fund Managers's 13F filing for Q2 2026, filed 24 Jul 2026.